Award

Colorado FOIA #1001985506

D-AP5 is a selective NMDA receptor antagonist that competes with glutamate binding and is commonly used to inhibit NM...

Recipient

R&D Systems Inc

Award Amount

$567.00

Ceiling

$567.00

Awarded

May 20, 2024

Identifier

1001985506

Description

D-AP5 is a selective NMDA receptor antagonist that competes with glutamate binding and is commonly used to inhibit NMDA-dependent synaptic plasticity.; SR 95531 hydrobromide__SR 95531 hydrobromide is a selective, competitive GABAA receptor antagonist and allosteric inhibitor (IC50 = 200 nM).